Marit Otterlei

Chief Scientific Officer at APIM Therapeutics - Ris, Auvergne, France

Marit Otterlei's Contact Details
HQ
Location
Trondheim,Trondelag,Norway
Company
APIM Therapeutics
Marit Otterlei's Company Details
APIM Therapeutics logo, APIM Therapeutics contact details

APIM Therapeutics

Ris, Auvergne, France • 6 Employees
Pharmaceuticals

APIM Therapeutics is a venture capital financed Norwegian biotech company focusing on the development of novel treatments in the fields of oncology and inflammation. Our lead drug, ATX-101, is a first-in-class peptide drug candidate targeting a novel therapeutic intervention point involved in cellular stress defense mechanisms. ATX-101 is currently being tested in a phase I study in patients with advanced solid tumors.

Details about APIM Therapeutics
Frequently Asked Questions about Marit Otterlei
Marit Otterlei currently works for APIM Therapeutics.
Marit Otterlei's role at APIM Therapeutics is Chief Scientific Officer.
Marit Otterlei's email address is ***@apimtherapeutics.com. To view Marit Otterlei's full email address, please signup to ConnectPlex.
Marit Otterlei works in the Pharmaceuticals industry.
Marit Otterlei's colleagues at APIM Therapeutics are Jens-Peter Marschner, Maria-Niki Mylonakou, Kostas Alevizopoulos and others.
Marit Otterlei's phone number is
See more information about Marit Otterlei